中国农村的受补贴妊娠糖尿病查和管理计划:一个务实的多中心,随机对照试验
Tingting Xu1,2, Qing Xia3, Xiaozhen Lai2,4
1Department of Health Management and Policy, School of Public Health, Capital Medical University, Beijing, 100069, China.
BMC medicine
|March 5, 2024
概括
中国农村的一个孕期糖尿病 (GDM) 补贴计划通过激励查和管理,改善了母亲和新生儿健康结果. 这一举措加强了服务不足地区的护理.
科学领域:
- 公共卫生 公共卫生
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 孕期糖尿病 (GDM) 的患病率正在上升,这在中国农村地区带来了挑战,控制率低于最佳水平.
- 服务不足的地区在GDM选和管理方面面临特别困难.
- 评估有针对性的干预措施对于改善母亲和婴儿健康结果至关重要.
研究的目的:
- 评估GDM补贴计划在加强中国农村人口GDM查和管理方面的有效性.
- 确定补贴计划对联合产妇和新生儿并发症的影响.
- 探索该计划对生活方式因素和医疗保健利用的影响.
主要方法:
- 一个多中心随机对照试验 (RCT),涉及中国农村3294名孕妇.
- 参与者被分配到补贴的GDM护理干预或常规护理.
- 主要结局包括联合的孕产妇和新生儿并发症;次要结局包括查率,管理遵守和生活方式因素.
主要成果:
- 干预组显示,联合产妇和/或新生儿并发症显著减少 (调整OR=0.86,P=0.001),特别是在GDM亚组 (调整OR=0.66,P=0.025).
- 在两组中,GDM查率都很高,干预组略有优势 (97.2%对94.5%).
- 干预组表现出更健康的生活方式选择,包括更低的能量摄入量,增加体力活动,以及更频繁的葡萄糖检测.
结论:
- 一个GDM护理计划为孕妇和医疗保健提供者提供了经济激励,有效地改善了中国农村的孕产妇和新生儿健康.
- 中国的公共卫生战略应该考虑整合GDM查和管理补贴,以加强生殖健康.
- 该研究强调了经济激励在解决医疗保健差异和改善资源有限的环境中GDM结果方面的潜力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes
928
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260


